Adaptive Person Based Signal Control System in Isolated Connected Vehicle Junction

Urban person delay and congestion have becoming an increasing important issues. Connected vehicle (CV) technologies offer opportunities for managing urban traffic efficiently to reduce vehicle delays. The adaptive signal controls in CV environments are vehicle based controls, ignoring the importance of reducing person delay and improving person mobility in urban areas. This paper proposes an innovative Adaptive Person Based Signal Control Algorithm (APBSCA) to minimize person delay at isolated urbans. APBSCA is able to explore flexible phase combinations and stage sequences to find optimal signal timing solutions in certain prediction horizon. The vehicle in formation including positions, speeds and occupancy levels are collected through CV technology as data sources. A three-level dynamic programming approach is adopted in APBSCA to update the predictive departure time of every vehicle surrounding junctions, which is affected by network environments and signal decisions. APBSCA figures out optimal signal timing parameters that yield highest person delay saving values indicators at isolated junction over the prediction period and implement the corresponding signal timings. The results indicate that APBSCA have better results in reducing average person delay in vehicle in terms of high occupancy vehicles. APBSCA offers significantly average person delay reduction up to 55%. The proposed APBSCA indicates that person based controls have potential benefits in reducing person delay to consistent the future urban goals of improving perso

Developing and evaluating a coordinated person-based signal control paradigm in a corridor network

Connected Vehicles (CVs) provide both vehicle trajectory data and occupancy information to the junction controller, which make person-based signal controls to be possible by realizing the importance of reducing person delay. This study presents a coordinated person-based signal control algorithm (C-PBC), which has extended a previously developed approach from isolated junctions to multiple junctions. C-PBC incorporates vehicle information that is outside the CV communication range from the adjacent junction. It also updates data inputs for signal optimization algorithms based on formulated different arrival vehicle trajectory situations and coordinated data supplement algorithms. The developed algorithm has been evaluated using simulation with benchmarking signal control methods under a variety of scenarios involving CV penetration rates and predictive horizons. The results indicate that C-PBC is able to significantly improve person delay reduction when compared with fixed time control and vehicle-based control using CV data in 100% CV penetration rate under saturated flow conditions

Sim-heuristics low-carbon technologies’ selection framework for reducing costs and carbon emissions of heavy goods vehicles

UK logistics fleets face increasing competitive pressures due to volatile fuel prices and the small profit margins in the industry. By reducing fuel consumption, operational costs and carbon emissions can be reduced. While there are a number of technologies that can reduce fuel consumption, it is often difficult for logistics companies to identify which would be the most beneficial to adopt over the medium and long terms. With a myriad of possible technology combinations, optimising the vehicle specification for specific duty cycles requires a robust decision-making framework. This paper combines simulated truck and delivery routes with a metaheuristic evolutionary algorithm to select the optimal combination of low-carbon technologies that minimise the greenhouse gas emissions of long-haul heavy goods vehicles during their lifetime cost. The framework presented is applicable to other vehicles, including road haulage, waste collection fleets and buses by using tailored parameters in the heuristics model

Boxed up and locked up, safe and tight! Making the case for unattended electronic locker bank logistics for an innovative solution to NHS hospital supplies (UK)

YesThe lack of separation between urgent and non-urgent medical goods encourages sub-optimal vehicle fleet operations owing to the time critical nature of urgent items. An unattended electronic locker bank, to which individual urgent items can be delivered thereby separating urgent and non-urgent supply, was proposed for the Great Ormond Street Hospital in London, UK. This concept was quantified using ‘basic’ and ‘intuitive’ hill climbing optimisation models; and qualitatively using staff interviews and expert reviews. Results indicated that a locker bank with a fixed height (1.7 m) and depth (0.8 m) required a length of 4 m (basic model) and 3.63 m (intuitive model), to accommodate 100% of urgent consignments for a typical week. Staff interviews indicated the wider benefits such as staff personal deliveries

Antibiotics for exacerbations of asthma.

BACKGROUND: Asthma is a chronic respiratory condition that affects over 300 million adults and children worldwide. It is characterised by wheeze, cough, chest tightness, and shortness of breath. Symptoms typically are intermittent and may worsen over a short time, leading to an exacerbation. Asthma exacerbations can be serious, leading to hospitalisation or even death in rare cases. Exacerbations may be treated by increasing an individual's usual medication and providing additional medication, such as oral steroids. Although antibiotics are sometimes included in the treatment regimen, bacterial infections are thought to be responsible for only a minority of exacerbations, and current guidance states that antibiotics should be reserved for cases in which clear signs, symptoms, or laboratory test results are suggestive of bacterial infection. OBJECTIVES: To determine the efficacy and safety of antibiotics in the treatment of asthma exacerbations. SEARCH METHODS: We searched the Cochrane Airways Trials Register, which contains records compiled from multiple electronic and handsearched resources. We also searched trial registries and reference lists of primary studies. We conducted the most recent search in October 2017. SELECTION CRITERIA: We included studies comparing antibiotic therapy for asthma exacerbations in adults or children versus placebo or usual care not involving an antibiotic. We allowed studies including any type of antibiotic, any dose, and any duration, providing the aim was to treat the exacerbation. We included parallel studies of any duration conducted in any setting and planned to include cluster trials. We excluded cross-over trials. We included studies reported as full-text articles, those published as abstracts only, and unpublished data. DATA COLLECTION AND ANALYSIS: At least two review authors screened the search results for eligible studies. We extracted outcome data, assessed risk of bias in duplicate, and resolved discrepancies by involving another review author. We analysed dichotomous data as odds ratios (ORs) or risk differences (RDs), and continuous data as mean differences (MDs), all with a fixed-effect model. We described skewed data narratively. We graded the results and presented evidence in 'Summary of findings' tables for each comparison. Primary outcomes were intensive care unit/high dependence unit (ICU/HDU) admission, duration of symptoms/exacerbations, and all adverse events. Seconday outcomes were mortality, length of hospital admission, relapse after index presentation, and peak expiratory flow rate (PEFR). MAIN RESULTS: Six studies met our inclusion criteria and included a total of 681 adults and children with exacerbations of asthma. Mean age in the three studies in adults ranged from 36.2 to 41.2 years. The three studies in children applied varied inclusion criteria, ranging from one to 18 years of age. Five studies explicitly excluded participants with obvious signs and symptoms of bacterial infection (i.e. those clearly meeting current guidance to receive antibiotics). Four studies investigated macrolide antibiotics, and two studies investigated penicillin (amoxicillin and ampicillin) antibiotics; both studies using penicillin were conducted over 35 years ago. Five studies compared antibiotics versus placebo, and one was open-label. Study follow-up ranged from one to twelve weeks. Trials were of varied methodological quality, and we were able to perform only limited meta-analysis.None of the included trials reported ICU/HDU admission, although one participant in the placebo group of a study including children with status asthmaticus experienced a respiratory arrest and was ventilated. Four studies reported asthma symptoms, but we were able to combine results for only two macrolide studies of 416 participants; the MD in diary card symptom score was -0.34 (95% confidence interval (CI) -0.60 to -0.08), with lower scores (on a 7 point scale) denoting improved symptoms. Two macrolide studies reported symptom-free days. One study of 255 adults authors reported the percentage of symptom-free days at 10 days as 16% in the antibiotic group and 8% in the placebo group. In a further study of 40 children study authors reported significantly more symptom-free days at all time points in the antibiotic group compared with the usual care group. The same study reported the duration in days of the index asthma exacerbation, again favouring the antibiotic group. One study of a penicillin including 69 participants reported asthma symptoms at hospital discharge; the between-group difference for both studies was reported as non-significant.We combined data for serious adverse events from three studies involving 502 participants, but events were rare; the three trials reported only 10 events: five in the antibiotic group and five in the placebo group. We combined data for all adverse events (AEs) from three studies, but the effect estimate is imprecise (OR 0.99, 95% CI 0.69 to 1.43). No deaths were reported in any of the included studies.Two studies investigating penicillins reported admission duration; neither study reported a between-group difference. In one study (263 participants) of macrolides, two participants in each arm were reported as experiencing a relapse, defined as a further exacerbation, by the six-week time points. We combined PEFR endpoint results at 10 days for two macrolide studies; the result favoured antibiotics over placebo (MD 23.42 L/min, 95% CI 5.23 to 41.60). One study in children reported the maximum peak flow recorded during the follow-up period, favouring the clarithromycin group, but the confidence interval includes no difference (MD 38.80, 95% CI -11.19 to 88.79).Grading of outcomes ranged from moderate to very low quality, with quality of outcomes downgraded for suspicion of publication bias, indirectness, imprecision, and poor methodological quality of studies. AUTHORS' CONCLUSIONS: We found limited evidence that antibiotics given at the time of an asthma exacerbation may improve symptoms and PEFR at follow-up compared with standard care or placebo. However, findings were inconsistent across the six heterogeneous studies included, two of the studies were conducted over 30 years ago and most of the participants included in this review were recruited from emergency departments, limiting the applicability of findings to this population. Therefore we have limited confidence in the results. We found insufficient evidence about several patient-important outcomes (e.g. hospital admission) to form conclusions. We were unable to rule out a difference between groups in terms of all adverse events, but serious adverse events were rare

Potential of wireless power transfer for dynamic charging of electric vehicles

Wireless power transfer (WPT) offers a viable means of charging electric vehicles (EVs) whilst in a dynamic state (DWPT), mitigating issues concerning vehicle range, the size of on-board energy storage and the network distribution of static based charging systems. Such charge while driving technology has the capability to accelerate EV market penetration through increasing user convenience, reducing EV costs and increasing driving range indefinitely, dependent upon sufficient charging infrastructure. This study reviews current traction battery technologies, conductive and inductive charging processes, influential parameters specific to the dynamic charging state as well as highlighting notable work within the field of WPT charging systems. DWPT system requirements, specific to the driver, vehicle and infrastructure interaction environment are summarised and international standards highlighted to acknowledge the work that must be done within this area. It is important to recognise that the gap is not currently technological; instead, it is an implementation issue. Without necessary standardisation, system architectures cannot be developed and implemented without fear of interoperability issues between systems. For successful deployment, the technologies impact should be maximised with the minimum quantity of infrastructure and technology use, deployment scenarios and locations are discussed that have the potential to bring this to fruition

Patient safety culture among European cancer nurses - an exploratory, cross-sectional survey comparing data from Estonia, Germany, Netherlands and United Kingdom

Aim To explore the differences in perceived patient safety culture in cancer nurses working in Estonia, Germany, the Netherlands and the United Kingdom. Design An exploratory cross‐sectional survey. Methods In 2018, 393 cancer nurses completed the 12 dimensions of the Hospital Survey on Patient Safety Culture. Results The mean score for the overall patient safety grade was 61.3. The highest rated dimension was ‘teamwork within units' while ‘staffing' was the lowest in all four countries. Nurses in the Netherlands and in the United Kingdom, scored higher on ‘communication openness', the ‘frequency of events reported' and ‘nonpunitive response to errors', than nurses from Estonia or Germany. We found statistically significant differences between the countries for the association between five of the 12 dimensions with the overall patient safety grade: overall perception of patient safety, communication openness, staffing, handoffs and transitions and nonpunitive response to errors. Conclusion Patient safety culture, as reported by cancer nurses, varies between European countries and contextual factors, such as recognition of the nursing role and education have an impact on it. Cancer nurses' role in promoting patient safety is a key concern and requires better recognition on a European and global level